MANDIE SHAW: Open Payments
NPI 1114475332 · CLEARFIELD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,026 in 63 payments from 10 companies in 2025. Trend: 2023 $937 · 2024 $1,103 · 2025 $1,026
Food & beverage: $1,026
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $552 |
| Collegium Pharmaceutical, Inc. | 7 | $123 |
| Astellas Pharma US Inc | 4 | $86 |
| Novo Nordisk Inc | 5 | $79 |
| Lundbeck LLC | 3 | $57 |
| PFIZER INC. | 3 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Alkermes, Inc. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
Products named: VRAYLAR, QULIPTA, UBRELVY, Jornay PM, Veozah, REXULTI, Ozempic, NURTEC ODT.
Industry payments across PA — which companies pay providers there.
